COMP <GO>
TPCS vs TMO // RETURN ON INVESTED CAPITAL (ROIC)
TechPrecision Corporation (NASDAQ) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: TPCS 0
— TMO 10
▲ RETURN ON INVESTED CAPITAL (ROIC) LEADER: TMO
LAST: $5.53 (+0.73%) • MKT CAP: $56.0M
roic
-10.60%
LAST: $709.18 (+0.71%) • MKT CAP: $262.22B
roic
9.30%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (TPCS VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | TPCS | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 15.70% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) ACTIVE | -10.60% | 9.30% | -19.90 | TMO | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 30.4x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -5.82% | 2.40% | -8.22 | TMO | /fcf-yield <GO> |
| Operating Margin | -3.40% | 17.40% | -20.80 | TMO | /operating-margins <GO> |
| Net Profit Margin | -5.30% | 15.10% | -20.40 | TMO | /net-margins <GO> |
| Revenue Growth (YoY) | -7.00% | 3.90% | -10.90 | TMO | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.24% | -0.24 | TMO | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 1.71 | 4.50 | -2.79 | TMO | /balance-sheet <GO> |
| Piotroski F-Score Quality | 3/9 | 8/9 | -5.00 | TMO | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 46.8 | 62.9 | -16.10 | TMO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.94 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 36.3x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $56.0M | $262.22B | -$262.16B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | TPCS REV | TMO REV | TPCS GROSS % | TMO GROSS % | TPCS FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $31.6M | $44.56B | 15.7% | — | -$3.3M | $6.29B |
| FY 2024 | $34.0M | $42.88B | 12.7% | — | -$4.7M | $7.27B |
| FY 2023 | $31.6M | $42.86B | — | — | $728.0K | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
TPCS // BETA —
TMO // BETA 0.94